Gufic Biosciences Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting
29-05-2026 | 10:35 pm
29-05-2026 | 10:35 pm
Gufic Biosciences' board approved the consolidated financial results for the quarter and financial year ended March 31, 2026. FY26 consolidated revenue was Rs 944.01 Cr, with a net profit of Rs 64.21 Cr. A final dividend of Re 0.10/share was proposed.
No comments yet. Be the first to comment!
